Esketamine (ESK) nasal spray monotherapy was found to be efficacious over placebo in adults with treatment-resistant depression, according to recent randomized, double-blind study results reported in a...
In this video, Nurse Penn and Dr Jain examine hyperbolic tapering, using liquid medications, the half-life and pharmacokinetics of fluoxetine, discussing processes with patients, and more.
Esketamine (ESK) nasal spray monotherapy was found to be efficacious over placebo in adults with treatment-resistant depression, according to recent randomized, double-blind study results reported in a...
Rates of clinically diagnosed depression and anxiety without depression increased between 2017 and 2021, especially during the COVID-19 pandemic, according to recent cohort study results published in JAMA...
Chronic pain in youth was associated with an increased risk of anxiety and depression, particularly when compared to symptoms of youth without chronic pain. Results from the systematic review and...
Increases in depressive symptoms during adolescence can persist into young adulthood, according to recent cohort study results published in JAMA Network Open.
More than one-third of young adults in the United States were found to have had anxiety or depression during the COVID-19 pandemic in a cross-sectional study recently published in JAMA Network Open. ...
